Immune-Related Sclerosing Cholangitis and Subsequent Pyogenic Liver Abscesses in Two Patients With Melanoma Treated by Triplet Therapy: A Case Report

Pembrolizumab-related cholangitis with multiple fatal liver abscesses after endoscopic biliary drainage: a case report and review of the literature

(2022) Hitomi Hori et al.   Clinical Journal of Gastroenterology

Management of toxicities from immunotherapy: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

(2022) J. Haanen et al.   ANNALS OF ONCOLOGY

Immune-related cholangitis induced by immune checkpoint inhibitors

(2021) Borui Pi et al.   EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY

Drug-induced bile duct injury: new agents, new mechanisms

(2021) Jean-Yves Scoazec   CURRENT OPINION IN GASTROENTEROLOGY

Rationale for Immune Checkpoint Inhibitors Plus Targeted Therapy in Metastatic Melanoma

(2020) Reinhard Dummer et al.   JAMA Oncology

Three cases of immune cholangitis related to anti–programmed cell death and programmed cell death ligand agents for the treatment of non-small cell lung cancer

(2019) Maxime Fouchard et al.   EUROPEAN JOURNAL OF CANCER

Tokyo Guidelines 2018: initial management of acute biliary infection and flowchart for acute cholangitis

(2018) Fumihiko Miura et al.   Journal of Hepato-Biliary-Pancreatic Sciences

A Population-Based Study of Pyogenic Liver Abscesses in the United States: Incidence, Mortality and Temporal Trends

(2009) Liisa Meddings et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY